2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine has been researched along with diethylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanck, A; Gustafsson, JA; Kleman, M; Overvik, E | 1 |
| Hasegawa, R; Ito, N; Nagao, M; Shirai, T; Sugimura, T; Tamano, S; Tanaka, H | 1 |
2 other study(ies) available for 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine and diethylnitrosamine
| Article | Year |
|---|---|
The food-mutagens 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine (PhIP) and 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) initiate enzyme-altered hepatic foci in the resistant hepatocyte model.
Topics: Animals; Diethylnitrosamine; Drug Resistance; gamma-Glutamyltransferase; Imidazoles; Liver; Male; Meat; Mutagens; Quinoxalines; Rats; Rats, Inbred Strains | 1989 |
Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay.
Topics: 1,2-Dimethylhydrazine; Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Diethylnitrosamine; Dimethylhydrazines; Dose-Response Relationship, Drug; Drug Synergism; Imidazoles; Intestinal Neoplasms; Male; Methylnitrosourea; Nitrosamines; Organ Size; Rats; Rats, Inbred F344 | 1994 |